Form 4: Moderna CFO Reports Stock Transactions

Moderna's Chief Financial Officer, James M. Mock, reported transactions involving restricted stock units and common stock, including tax withholdings.

Summary

• James M. Mock, Chief Financial Officer of Moderna, Inc., reported transactions on April 2, 2026.
• These transactions involved the conversion of restricted stock units (RSUs) into common stock and the disposal of common stock.
• Specifically, 1,453 RSUs converted into common stock, and 703 shares were disposed of to cover tax withholding obligations at a price of $50.03 per share.
• Following these transactions, Mock beneficially owns 57,748 shares of common stock.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it represents routine insider stock transactions related to equity compensation and tax obligations, rather than significant strategic or financial events.

Positives

• The conversion of RSUs into common stock indicates the vesting and realization of equity compensation for the CFO.
• The disposal of shares to cover tax withholding is a standard and expected event upon equity vesting, demonstrating responsible financial management by the executive.

Negatives

• The disposal of 703 shares for tax withholding represents a reduction in the CFO's direct beneficial ownership of common stock.

Future Outlook

No specific future outlook or guidance is provided in this Form 4 filing, which solely reports past transactions.

Industry Context

StockSavvy.ai notes that Form 4 filings are routine disclosures for corporate insiders and reflect standard equity compensation management. The transactions reported by Moderna's CFO are typical for executives receiving stock-based compensation and do not inherently signal a change in the company's strategic direction or financial health.

Stakeholder Impact

• Shareholders: The filing provides transparency into executive stock ownership, which is a standard disclosure. The transactions themselves are typical for equity compensation and do not inherently suggest a change in company performance.
• Employees: The CFO's equity transactions are part of their compensation package and do not directly impact other employees.
• Creditors: No direct impact on creditors is indicated by this filing.
• Suppliers: No direct impact on suppliers is indicated by this filing.
• Customers: No direct impact on customers is indicated by this filing.

Key Dates

Keywords

Moderna, MRNA, Form 4, Insider Trading, Stock Transaction, Restricted Stock Units, Common Stock, Beneficial Ownership, Tax Withholding, Chief Financial Officer